Peers: AMGN LLY MRK JNJ PFE BIIB BMY VRTX GILD REGN

| Held by: IJR VTI AVUV IWM VB XBI FBT VBK VXF SPSM

Index	RUT	P/E	24.32	EPS (ttm)	1.43	Insider Own	2.02%	Shs Outstand	165.61M	Perf Week	16.44%
Market Cap	5.81B	Forward P/E	47.61	EPS next Y	0.73	Insider Trans	-3.99%	Shs Float	163.28M	Perf Month	18.99%
Enterprise Value	4.56B	PEG	-	EPS next Q	-0.54	Inst Own	108.48%	Short Float	12.62%	Perf Quarter	24.52%
Income	241.66M	P/S	3.93	EPS this Y	-133.51%	Inst Trans	3.61%	Short Ratio	8.68	Perf Half Y	13.67%
Sales	1.48B	P/B	3.17	EPS next Y	252.74%	ROA	10.54%	Short Interest	20.60M	Perf YTD	24.52%
Book/sh	10.99	P/C	4.40	EPS next 5Y	-3.05%	ROE	14.72%	52W High	36.48 -4.50%	Perf Year	6.71%
Cash/sh	7.92	P/FCF	12.09	EPS past 3/5Y	- -	ROIC	12.84%	52W Low	25.17 38.45%	Perf 3Y	32.95%
Dividend Est.	-	EV/EBITDA	16.21	Sales past 3/5Y	9.90% 7.28%	Gross Margin	86.31%	Volatility	5.61% 4.01%	Perf 5Y	95.71%
Dividend TTM	-	EV/Sales	3.09	EPS Y/Y TTM	-34.36%	Oper. Margin	17.21%	ATR (14)	1.46	Perf 10Y	5.07%
Dividend Ex-Date	-	Quick Ratio	3.19	Sales Y/Y TTM	-5.25%	Profit Margin	16.37%	RSI (14)	70.71	Recom	1.41
Dividend Gr. 3/5Y	- -	Current Ratio	3.55	EPS Q/Q	-66.92%	SMA20	18.59%	Beta	0.39	Target Price	43.53
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	-10.57%	SMA50	10.90%	Rel Volume	1.05	Prev Close	35.05
Employees	2050	LT Debt/Eq	0.03	Earnings	Feb 25 BMO	SMA200	17.19%	Avg Volume	2.37M	Price	34.84
IPO	Jul 16, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	-29.30% 1.48%	Trades		Volume	2,485,560	Change	-0.60%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-26	Initiated	Wolfe Research	Outperform	$45
Nov-11-25	Initiated	Truist	Buy	$50
Sep-26-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$44
Sep-03-25	Initiated	Wells Fargo	Overweight	$44
Jul-15-25	Initiated	Goldman	Buy	$43
Jun-17-25	Upgrade	UBS	Neutral → Buy	$42
May-28-25	Initiated	Needham	Buy	$45
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$40
Mar-04-25	Upgrade	UBS	Sell → Neutral	$21 → $38
Feb-11-25	Initiated	Deutsche Bank	Buy	$40
Nov-05-24	Upgrade	Stifel	Hold → Buy	$25 → $36
Jun-17-24	Initiated	TD Cowen	Buy	$34
Mar-19-24	Initiated	Robert W. Baird	Outperform	$37
Feb-20-24	Downgrade	UBS	Neutral → Sell	$25
Nov-20-23	Resumed	JP Morgan	Neutral	$33
Oct-24-23	Upgrade	Evercore ISI	In-line → Outperform
Oct-17-23	Initiated	UBS	Neutral	$31
Nov-03-22	Upgrade	Piper Sandler	Neutral → Overweight	$26 → $30
Oct-14-22	Upgrade	BofA Securities	Underperform → Neutral	$27 → $25
Aug-16-22	Initiated	Piper Sandler	Neutral	$26

Show Previous Ratings

Apr-01-26 07:00AM	Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 (Business Wire)
Mar-12-26 07:00AM	Alkermes Announces Inaugural Alkermes Pathways APN Research Awards Program (Business Wire)
Mar-11-26 05:11AM	New Strong Sell Stocks for March 11th (Zacks)
Mar-10-26 04:00PM	Alkermes to Present at the Stifel 2026 Virtual CNS Forum (Business Wire)
Mar-06-26 03:00AM	Biopharmas recent string of CEO splits (Pharma Voice)
10:02PM	Loading…
Mar-02-26 10:02PM	Alkermes Pivots Deeper Into Sleep Medicine After Avadel Deal, Details Orexin Phase 3 at TD Cowen (MarketBeat)
Feb-26-26 11:40AM	Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change (Zacks)
Feb-25-26 02:03PM	Alkermes PLC (ALKS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -7.04%
12:32PM	Alkermes plc Q4 2025 Earnings Call Summary (Moby)
12:30PM	Alkermes (ALKS) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
12:15PM	Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates (Zacks)
11:02AM	Alkermes Q4 Earnings Call Highlights (MarketBeat)
07:43AM	Alkermes: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 (Business Wire)
06:55AM	Alkermes plc Announces CEO Succession Plan (Business Wire)
06:54AM	Loading…
06:54AM	Alkermes Richard Pops to step down after three-decade run as CEO (BioPharma Dive)
Feb-24-26 04:00PM	Alkermes to Present at the TD Cowen 46th Annual Health Care Conference (Business Wire)
09:15AM	Wall Street's Insights Into Key Metrics Ahead of Alkermes (ALKS) Q4 Earnings (Zacks)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Blackstone, Blue Owl Capital, Booking Holdings, Cheniere Energy, Comcast, Dominos Pizza, KeyCorp, Qualcomm, and More (24/7 Wall St.)
Feb-19-26 11:59AM	BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth (Zacks)
07:34AM	ImmunityBio Wins EU Nod for Bladder Cancer Combo Therapy, Stock Up (Zacks)
Feb-18-26 11:31AM	FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma (Zacks)
11:24AM	Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark (Zacks)
09:41AM	EU Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients (Zacks)
09:40AM	Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:32AM	Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo (Zacks)
Feb-17-26 12:10PM	Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Feb-13-26 01:11PM	Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
12:55PM	SNY Stock Falls After Board Suddenly Makes Leadership Change (Zacks)
11:53AM	VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales (Zacks)
10:33AM	Loading…
10:33AM	Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss (Zacks)
10:23AM	Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y (Zacks)
10:20AM	NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia (Zacks)
10:19AM	ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down (Zacks)
10:04AM	CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates (Zacks)
Feb-12-26 10:38AM	MDGL Strengthens MASH Franchise With New Genetic Approaches (Zacks)
10:30AM	Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates (Zacks)
07:30AM	Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market (Business Wire)
Feb-11-26 04:00PM	Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 (Business Wire)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
10:45AM	MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA (Zacks)
Feb-10-26 10:43AM	SNY's Rare Disease Drug Wins FDA Breakthrough and Japan Orphan Status (Zacks)
10:38AM	INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales (Zacks)
Feb-09-26 11:42AM	IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus (Zacks)
Feb-06-26 01:58PM	Mettler-Toledo Q4 Earnings Top Estimates, Sales Rise Y/Y (Zacks)
11:45AM	GSK Gets EU Approval for Expanded Use of Nucala in COPD (Zacks)
11:31AM	KOD Stock Up 24% in 3 Months: Here's What You Need to Know (Zacks)
Feb-05-26 11:42AM	Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results (Zacks)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-04-26 10:11AM	FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to Datroway (Zacks)
09:16AM	NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View (Zacks)
Feb-03-26 11:59AM	Sanofi's Venglustat Meets Primary Endpoints in Gaucher Disease Study (Zacks)
11:36AM	MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '26 View (Zacks)
10:43AM	NVO's CagriSema Outshines Semaglutide in Phase III Diabetes Study (Zacks)
09:27AM	Here's Why Gilead Sciences Stock Surged 21% in a Month (Zacks)
07:52AM	Acadia Expects Negative CHMP Opinion for Rett Syndrome Drug in EU (Zacks)
Feb-02-26 11:03AM	Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome (Zacks)
09:40AM	Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-30-26 10:24AM	FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug (Zacks)
10:11AM	KYMR Initiates Dosing in Mid-Stage Asthma Study of Lead Candidate (Zacks)
Jan-29-26 11:52AM	HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance (Zacks)
11:23AM	TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth (Zacks)
08:53AM	Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status (Zacks)
08:34AM	Are Options Traders Betting on a Big Move in Alkermes Stock? (Zacks)
Jan-28-26 09:45AM	NTLA Stock Up More Than 6% as FDA Lifts ATTRv-PN Study Clinical Hold (Zacks)
Jan-27-26 02:07PM	BHC's Late-Stage Liver Cirrhosis Studies Fail, Stock Down (Zacks)
12:15PM	Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why (Zacks)
10:53AM	RVMD Stock Tumbles as MRK Reportedly Withdraws Buyout Offer (Zacks)
10:50AM	SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD (Zacks)
Jan-23-26 11:13AM	CORT Rises as Relacorilant Meets OS Endpoint in Ovarian Cancer Study (Zacks)
Jan-22-26 02:17PM	Alkermes Stock Earns Technical Rating Upgrade (Investor's Business Daily)
11:39AM	MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data (Zacks)
03:09AM	Jim Cramer on Alkermes: "I Think It's a Hold, Maybe a Weak One" (Insider Monkey)
Jan-21-26 10:46AM	ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission (Zacks) +6.61%
10:31AM	FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate (Zacks)
10:12AM	NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies (Zacks)
Jan-19-26 10:36AM	ImmunityBio Shares Surge on Updated Durable Lymphoma Study Results (Zacks)
09:17AM	CytomX Stock Rises 31% in a Month: Here's What You Should Know (Zacks)
Jan-16-26 08:28PM	Lightning Round: Medline is 'unbelievable', it's a buy, says Jim Cramer (CNBC TV)
11:08AM	Mirum Stock Rises 7% in a Week: Here's What You Should Know (Zacks)
09:06AM	Erasca Stock Surges 42% in a Week: Here's What You Should Know (Zacks)
Jan-15-26 11:16AM	Apellis Stock Crashes 23% in a Week: Here's What You Should Know (Zacks)
09:40AM	Are Medical Stocks Lagging Alkermes (ALKS) This Year? (Zacks)
Jan-14-26 12:10PM	Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report? (Zacks) +5.04%
10:18AM	PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific (Zacks)
03:33AM	Best Value Stocks to Buy for Jan.14 (Zacks)
Jan-13-26 06:23PM	Alkermes Touts $10B Sleep Market as ALKS 2680 Heads to Phase 3, Avidel Deal Nears Close (MarketBeat)
Jan-07-26 11:45AM	FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug (Zacks)
Jan-06-26 07:00AM	Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1 (Business Wire)
Dec-30-25 04:00PM	Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-22-25 06:50AM	Why Analysts are Rating Alkermes (ALKS) a Buy (Insider Monkey)
Dec-08-25 09:40AM	Are Investors Undervaluing Alkermes (ALKS) Right Now? (Zacks)
Nov-27-25 11:30AM	Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report? (Zacks)
Nov-25-25 04:00PM	Alkermes to Participate in Two Upcoming Investor Conferences (Business Wire)
Nov-20-25 12:33PM	AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results (Zacks)
09:14AM	ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal (Zacks)
Nov-19-25 04:22PM	Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck (Investor's Business Daily)
01:44PM	Alkermes prevails over Lundbeck in Avadel bidding war (Pharmaceutical Technology)
10:59AM	Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri (Zacks)
09:12AM	Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks (Zacks)

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Apr 01 '26	Option Exercise	19.34	5,000	96,700	94,389	Apr 01 06:58 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Apr 01 '26	Sale	35.51	9,000	319,604	85,389	Apr 01 06:58 PM
Hopkinson Craig C.	Officer	Apr 01 '26	Proposed Sale	35.51	9,000	319,604		Apr 01 04:13 PM
Parisi Samuel Joseph	VP, Finance (Interim PAO)	Mar 02 '26	Sale	29.29	6,890	201,808	7,717	Mar 04 08:19 PM
Nichols Christian Todd	SVP, Chief Commercial Officer	Mar 02 '26	Sale	30.00	6,000	180,000	109,769	Mar 04 08:18 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Mar 02 '26	Option Exercise	19.34	5,000	96,700	98,389	Mar 04 08:16 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Mar 02 '26	Sale	29.72	9,000	267,485	89,389	Mar 04 08:16 PM
Gaffin David Joseph	EVP, CLO, Alkermes, Inc.	Mar 03 '26	Sale	29.76	2,034	60,532	235,626	Mar 04 08:15 PM
Gaffin David Joseph	EVP, CLO, Alkermes, Inc.	Mar 02 '26	Sale	29.29	2,034	59,576	237,660	Mar 04 08:15 PM
Gaffin David Joseph	Officer	Mar 03 '26	Proposed Sale	29.76	2,034	60,532		Mar 03 05:12 PM
Nichols Christian Todd	Officer	Mar 02 '26	Proposed Sale	30.00	6,000	180,000		Mar 02 05:15 PM
Gaffin David Joseph	Officer	Mar 02 '26	Proposed Sale	29.29	2,034	59,576		Mar 02 05:07 PM
Hopkinson Craig C.	Officer	Mar 02 '26	Proposed Sale	29.72	9,000	267,485		Mar 02 04:36 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Feb 02 '26	Option Exercise	19.34	5,000	96,700	66,740	Feb 02 08:52 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Feb 02 '26	Sale	33.93	9,000	305,384	57,740	Feb 02 08:52 PM
Cooke Shane	Director	Feb 02 '26	Option Exercise	31.64	61,200	1,936,368	164,944	Feb 02 08:48 PM
Cooke Shane	Director	Feb 02 '26	Sale	34.57	61,200	2,115,673	103,744	Feb 02 08:48 PM
Cooke Shane	Officer	Feb 02 '26	Proposed Sale	34.57	61,200	2,115,674		Feb 02 04:05 PM
Hopkinson Craig C.	Officer	Feb 02 '26	Proposed Sale	33.93	9,000	305,384		Feb 02 04:02 PM
Hopkinson Craig C.	Officer	Jan 08 '26	Proposed Sale	30.00	5,000	150,005		Jan 08 07:38 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Jan 08 '26	Option Exercise	19.34	5,000	96,700	66,740	Jan 08 05:23 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Jan 08 '26	Sale	30.00	5,000	150,005	61,740	Jan 08 05:23 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Jan 02 '26	Sale	28.00	4,000	112,000	61,740	Jan 02 04:39 PM
Hopkinson Craig C.	Officer	Jan 02 '26	Proposed Sale	28.00	4,000	112,000		Jan 02 04:36 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Dec 03 '25	Option Exercise	19.34	3,748	72,486	69,488	Dec 05 04:21 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Dec 03 '25	Sale	30.00	3,748	112,447	65,740	Dec 05 04:21 PM
Hopkinson Craig C.	Officer	Dec 03 '25	Proposed Sale	30.00	3,748	112,447		Dec 03 04:32 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Dec 01 '25	Sale	29.30	4,000	117,200	65,740	Dec 01 05:41 PM
Hopkinson Craig C.	Officer	Dec 01 '25	Proposed Sale	29.30	4,000	117,200		Dec 01 04:45 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Nov 03 '25	Option Exercise	19.34	5,000	96,700	78,740	Nov 03 04:37 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Nov 03 '25	Sale	30.38	9,000	273,442	69,740	Nov 03 04:37 PM
Hopkinson Craig C.	Officer	Nov 03 '25	Proposed Sale	30.38	9,000	273,442		Nov 03 04:35 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Oct 15 '25	Option Exercise	19.34	5,000	96,700	82,740	Oct 15 06:47 PM
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Oct 15 '25	Sale	31.53	9,000	283,776	73,740	Oct 15 06:47 PM
Hopkinson Craig C.	Officer	Oct 15 '25	Proposed Sale	31.53	9,000	283,777		Oct 15 04:07 PM
Nichols Christian Todd	SVP, Chief Commercial Officer	Jun 09 '25	Sale	31.95	3,333	106,489	89,542	Jun 10 04:39 PM
Nichols Christian Todd	SVP, Chief Commercial Officer	Jun 10 '25	Sale	31.09	3,334	103,654	86,208	Jun 10 04:39 PM
Nichols Christian Todd	Officer	Jun 10 '25	Proposed Sale	31.09	3,334	103,654		Jun 10 04:29 PM
Nichols Christian Todd	Officer	Jun 09 '25	Proposed Sale	31.95	3,333	106,489		Jun 09 04:08 PM

Open in Screener

SYNA

Synaptics Inc

Apr 02 • 04:00PM ET

74.15

+1.57 2.16 %

Technology • Semiconductors • USA • NASD

Peers: AVGO QCOM NXPI ADI SWKS ON MCHP TXN MPWR SLAB

| Held by: VTI IJH VGT VB IWM VBR XSD VXF IWN MDY

Index	RUT	P/E	-	EPS (ttm)	-1.59	Insider Own	2.80%	Shs Outstand	38.71M	Perf Week	1.33%
Market Cap	2.87B	Forward P/E	14.20	EPS next Y	5.22	Insider Trans	-3.26%	Shs Float	37.65M	Perf Month	-3.74%
Enterprise Value	3.32B	PEG	0.67	EPS next Q	1.01	Inst Own	99.59%	Short Float	12.73%	Perf Quarter	0.18%
Income	-61.90M	P/S	2.51	EPS this Y	22.48%	Inst Trans	-0.04%	Short Ratio	6.12	Perf Half Y	9.20%
Sales	1.14B	P/B	2.07	EPS next Y	17.77%	ROA	-2.43%	Short Interest	4.79M	Perf YTD	0.18%
Book/sh	35.75	P/C	6.57	EPS next 5Y	21.22%	ROE	-4.49%	52W High	97.00 -23.56%	Perf Year	16.46%
Cash/sh	11.29	P/FCF	18.55	EPS past 3/5Y	- -	ROIC	-2.75%	52W Low	41.80 77.39%	Perf 3Y	-33.29%
Dividend Est.	-	EV/EBITDA	35.62	Sales past 3/5Y	-14.84% -4.24%	Gross Margin	41.59%	Volatility	6.34% 4.96%	Perf 5Y	-46.32%
Dividend TTM	-	EV/Sales	2.90	EPS Y/Y TTM	-137.22%	Oper. Margin	-6.16%	ATR (14)	4.01	Perf 10Y	-4.56%
Dividend Ex-Date	-	Quick Ratio	2.33	Sales Y/Y TTM	13.35%	Profit Margin	-5.41%	RSI (14)	48.96	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	2.93	EPS Q/Q	-941.81%	SMA20	1.59%	Beta	1.72	Target Price	102.18
Payout	-	Debt/Eq	0.64	Sales Q/Q	13.21%	SMA50	-7.11%	Rel Volume	0.82	Prev Close	72.58
Employees	1700	LT Debt/Eq	0.63	Earnings	Feb 05 AMC	SMA200	2.10%	Avg Volume	782.94K	Price	74.15
IPO	Jan 29, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.12% 0.74%	Trades		Volume	643,575	Change	2.16%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-25	Initiated	Wells Fargo	Overweight	$95
Dec-02-25	Initiated	Northland Capital	Outperform	$85
Nov-07-25	Reiterated	TD Cowen	Buy	$80 → $90
Sep-11-25	Initiated	Deutsche Bank	Buy	$85
Aug-18-25	Initiated	Barclays	Overweight	$78
May-09-25	Resumed	Needham	Buy	$80
Nov-08-24	Reiterated	TD Cowen	Buy	$90 → $100
Oct-08-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Aug-09-24	Reiterated	TD Cowen	Buy	$115 → $90
May-10-24	Reiterated	TD Cowen	Buy	$135 → $115
Feb-09-24	Reiterated	TD Cowen	Outperform	$115 → $135
Feb-09-24	Downgrade	Craig Hallum	Buy → Hold	$105
Dec-08-23	Initiated	JP Morgan	Overweight	$130
Feb-03-23	Downgrade	Oppenheimer	Outperform → Perform
May-06-22	Downgrade	Summit Insights	Buy → Hold
Apr-07-22	Initiated	Wells Fargo	Equal Weight	$185
Dec-08-21	Reiterated	Cowen	Outperform	$250 → $310
Nov-05-21	Upgrade	Summit Insights	Hold → Buy
Oct-05-21	Reiterated	KeyBanc Capital Markets	Overweight	$220 → $230
May-07-21	Reiterated	Craig Hallum	Buy	$130 → $160

Show Previous Ratings

Mar-10-26 03:00AM	Synaptics Introduces SYN765x, an Industry-Leading AI-Native Wi-Fi 7 Solution for Integrated IoT Edge Applications (GlobeNewswire)
03:00AM	Synaptics Expands Astra Edge AI Portfolio with SR80 Series for AI-enhanced Premium Audio and SRW1500 Series for Connected Distributed Intelligence (GlobeNewswire)
03:00AM	Google Research and Synaptics Launch Next-Generation Coral Dev Board for Developers to Bring Multimodal Edge AI Applications to Life (GlobeNewswire)
Feb-28-26 08:28AM	Synaptics Incorporated (SYNA): A Bull Case Theory (Insider Monkey)
Feb-19-26 11:01AM	Synaptics to Participate at Upcoming Investor Conferences Thursday, February 26, 2026 and Tuesday, March 3, 2026 (GlobeNewswire)
05:00AM	Loading…
Feb-09-26 05:00AM	Small Caps Flourish as US Earnings Growth Broadens Beyond Tech (Bloomberg)
Feb-06-26 06:33AM	Synaptics Slips Despite Beating Q2 Estimates (GuruFocus.com)
01:36AM	Synaptics Q2 Earnings Call Highlights (MarketBeat)
12:02AM	Synaptics Inc (SYNA) Q2 2026 Earnings Call Highlights: Strong IoT Growth Amidst Supply Challenges (GuruFocus.com)
Feb-05-26 06:30PM	Synaptics (SYNA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:45PM	Synaptics (SYNA) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:47PM	Synaptics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Synaptics Reports Second Quarter Fiscal 2026 Results (GlobeNewswire)
Jan-15-26 11:01AM	Synaptics to Report Second Quarter Fiscal 2026 Results on February 5, 2026 (GlobeNewswire)
Jan-08-26 12:00PM	Synaptics (SYNA) Upgraded to Buy: Here's Why (Zacks)
11:01AM	Loading…
11:01AM	Synaptics to Participate at Upcoming Investor Conference Tuesday, January 13, 2026 (GlobeNewswire)
Jan-05-26 08:55AM	Synaptics Appoints Venkatesh (Venk) Nathamuni to Board of Directors (GlobeNewswire)
Dec-25-25 12:00PM	Wells Fargo Bullish on Synaptics (SYNA) Due to Attractive Risk/Reward Profile (Insider Monkey)
Dec-19-25 09:43AM	Circle Internet initiated, Lyft downgraded: Wall Street's top analyst calls (The Fly)
07:56AM	Here Are Fridays Top Wall Street Analyst Research Calls: Birkenstock, Coreweave, Lockheed Martin, Lyft, Paccar, Stryker, Synaptics, and More (24/7 Wall St.)
Dec-17-25 12:03AM	Synaptics Showcases Edge AI Innovations at CES 2026 (GlobeNewswire)
Nov-25-25 09:05AM	Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025 (GlobeNewswire)
Nov-17-25 12:20PM	Synaptics (SYNA) Partners with Qualcomm to Advance Next-Generation Touch and Fingerprint Sensor Technologies (Insider Monkey)
Nov-14-25 08:04AM	Synaptics to Participate at Upcoming Investor Conference Wednesday, November 19, 2025 (GlobeNewswire)
Nov-12-25 08:45AM	Synaptics and Qualcomm Partner to Advance Fingerprint and Touch Technology Across PC and Mobile Platforms (GlobeNewswire)
Nov-07-25 12:08AM	Synaptics Inc (SYNA) Q1 2026 Earnings Call Highlights: Strong IoT Growth and New Product ... (GuruFocus.com)
Nov-06-25 08:30PM	Compared to Estimates, Synaptics (SYNA) Q1 Earnings: A Look at Key Metrics (Zacks)
08:00PM	Synaptics (SYNA) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
06:54PM	Synaptics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Synaptics Reports First Quarter Fiscal 2026 Results (GlobeNewswire)
07:37AM	Loading…
07:37AM	Amazons $300 Billion Jump Puts Stock Back in AI Conversation (Bloomberg)
Nov-05-25 05:15PM	Qualcomm (QCOM) Q4 Earnings and Revenues Surpass Estimates (Zacks)
10:17AM	What's in Store for These 5 Semiconductor Stocks This Earnings Season? (Zacks)
Oct-30-25 08:25AM	Allegro MicroSystems, Inc. (ALGM) Q2 Earnings Beat Estimates (Zacks)
Oct-16-25 11:01AM	Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2025 (GlobeNewswire)
07:53AM	Navitas Semiconductor (NVTS) Moves 20.6% Higher: Will This Strength Last? (Zacks)
Oct-15-25 09:00AM	Synaptics Launches the Next Generation of Astra Multimodal GenAI Processors to Power the Future of the Intelligent IoT Edge (GlobeNewswire)
Sep-24-25 01:05AM	Deutsche Bank Gives Synaptics (SYNA) a Buy Rating (Insider Monkey)
Sep-16-25 02:58PM	Synaptics, Righ Partner to Develop Agentic AI for Smart Homes, Showcases Cloud-Independent Solution (Insider Monkey)
Sep-11-25 09:47AM	Apple downgraded, Nvidia upgraded: Wall Street's top analyst calls (The Fly)
Sep-08-25 01:16PM	Synaptics to demonstrate how AI-native processing enables MSOs and OTT streamers to deliver new features at IBC 2025 (GlobeNewswire)
Aug-25-25 07:03AM	Synaptics To Participate at Upcoming Investor Conferences on Thursday, August 28, 2025 and Thursday, September 4, 2025 (GlobeNewswire)
Aug-08-25 09:01PM	Synaptics Inc (SYNA) Q4 2025 Earnings Call Highlights: Strong IoT Growth and Strategic ... (GuruFocus.com) +6.40%
Aug-07-25 08:20PM	Synaptics (SYNA) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:25PM	Synaptics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results (GlobeNewswire)
Aug-06-25 08:33PM	Synaptics To Participate at Upcoming Investor Conference Monday, August 11, 2025 (GlobeNewswire)
05:15PM	Alpha and Omega Semiconductor (AOSL) Beats Q4 Earnings and Revenue Estimates (Zacks)
Aug-05-25 12:25PM	TD Cowen Reduces PT on Synaptics (SYNA) Stock (Insider Monkey)
Jul-21-25 12:14AM	Synaptics, Murata Partner to Develop Next-Gen Automotive Wireless Connectivity Modules (Insider Monkey)
Jul-16-25 04:08PM	Synaptics to Report Fourth Quarter and Full Year Fiscal 2025 Results on August 7, 2025 (GlobeNewswire)
Jun-05-25 09:55AM	Does Synaptics (SYNA) Have the Potential to Rally 40.62% as Wall Street Analysts Expect? (Zacks)
May-25-25 11:21PM	Synaptics sharpens edge AI focus with custom IP, Wi-Fi 7, next-gen MCUs (DigiTimes)
May-21-25 04:05PM	Synaptics Names Rahul Patel as President and Chief Executive Officer (GlobeNewswire)
May-20-25 09:55AM	Wall Street Analysts Predict a 37.73% Upside in Synaptics (SYNA): Here's What You Should Know (Zacks)
May-17-25 06:10AM	Needham Pounds the Table on 2 AI Stocks And Neither Is Nvidia (TipRanks)
May-09-25 12:06PM	Synaptics Announces Fiscal Fourth Quarter 2025 Investor Conference Participation (GlobeNewswire)
11:56AM	Q3 2025 Synaptics Inc Earnings Call (Thomson Reuters StreetEvents)
03:47AM	Synaptics Inc (SYNA) Q3 2025 Earnings Call Highlights: Strong IoT Growth and Wi-Fi 7 Launch ... (GuruFocus.com)
May-08-25 06:25PM	Synaptics (SYNA) Q3 Earnings and Revenues Surpass Estimates (Zacks)
05:26PM	Synaptics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Synaptics Reports Third Quarter Fiscal 2025 Results (GlobeNewswire)
May-07-25 10:05AM	What To Expect From Synaptics Inc (SYNA) Q3 2025 Earnings (GuruFocus.com)
May-06-25 05:40PM	Teradata (TDC) Surpasses Q1 Earnings Estimates (Zacks)
May-01-25 03:01AM	Synaptics and Murata Partner for Next-Generation Automotive Wireless Connectivity (GlobeNewswire)
Apr-30-25 02:33PM	Is Synaptics Incorporated (SYNA) the Cheap Semiconductor Stock to Buy Now? (Insider Monkey)
Apr-28-25 03:01AM	Synaptics Unveils First Veros Wi-Fi 7 Family Tailored for the IoT (GlobeNewswire)
Apr-15-25 05:03PM	Synaptics to Report Third Quarter Fiscal 2025 Results on May 8, 2025 (GlobeNewswire)
Apr-14-25 04:05AM	Synaptics Unveils Next-Generation Touch Controller Engineered for Foldable OLED Displays (GlobeNewswire)
Apr-08-25 02:23AM	Himax Technologies: A Stock On Sale Despite Many Catalysts (Seeking Alpha) -5.79%
Mar-31-25 11:42AM	Synaptics: A Painful Transition (Seeking Alpha)
Mar-24-25 08:35AM	FPA Queens Road Small Cap Value Fund Q4 2024 Commentary (SeekingAlpha)
Mar-14-25 02:25PM	Synaptics Incorporated (SYNA) Expands Veros Portfolio with Ultra-Low Power Wireless SoCs (Insider Monkey)
11:19AM	Synaptics (SYNA) Expands Astra AI-Native Platform with High-Performance Edge AI MCUs (Insider Monkey)
Mar-11-25 03:00AM	embedUR systems: Trusted Software Partner for Synaptics' SR-Series High-Performance Adaptive MCUs (PR Newswire)
Mar-10-25 06:05AM	Synaptics Launches Ultra-Low-Power Wi-Fi/Bluetooth/802.15.4 Triple Combo SoC Family for Embedded Edge AI IoT (GlobeNewswire)
06:04AM	Synaptics Extends Edge AI Portfolio with High-Performance Adaptive MCUs for Multimodal Context-Aware Computing (GlobeNewswire)
Mar-08-25 10:20AM	Synaptics Incorporated (SYNA) to Unveil Edge AI and Wireless Connectivity Solutions at Embedded World 2025 (Insider Monkey)
Mar-06-25 08:21AM	Several Headwinds Hit Synaptics (SYNA) in 2024 (Insider Monkey)
Mar-05-25 10:50AM	Is Synaptics Incorporated (SYNA) the Most Undervalued Semiconductor Stock to Buy Now? (Insider Monkey)
06:00AM	Synaptics Seeks to Alter the Trajectory of the IoT at Embedded World With Contextual Edge AI and Wireless Innovations (GlobeNewswire)
Feb-21-25 04:14PM	Is Synaptics (SYNA) the Most Oversold Semiconductor Stock in 2024? (Insider Monkey)
Feb-14-25 04:32PM	Synaptics Reports Inducement Grants Following Completion of Broadcom Agreement (GlobeNewswire)
Feb-08-25 06:17AM	Synaptics Incorporated (SYNA) Beats Q2 Estimates, Strengthens Edge AI and Wireless Connectivity (Insider Monkey)
Feb-07-25 02:27AM	Synaptics Inc (SYNA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-06-25 06:00PM	Synaptics (SYNA) Q2 Earnings and Revenues Top Estimates (Zacks)
04:59PM	Synaptics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Synaptics Reports Second Quarter Fiscal 2025 Results (GlobeNewswire)
Feb-05-25 07:08AM	Synaptics Inc (SYNA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 04:34PM	These Stocks Moved the Most Today: Palantir, Alphabet, Tesla, Merck, PayPal, Super Micro, Spotify, Estée Lauder, and More (Barrons.com) -12.59%
02:46PM	These Stocks Are Moving the Most Today: Palantir, Alphabet, Tesla, Merck, PayPal, Super Micro, Spotify, Estée Lauder, and More (Barrons.com)
Feb-03-25 04:05PM	Synaptics Announces CEO Transition (GlobeNewswire)
Jan-30-25 09:16PM	Synaptics Incorporated (SYNA) Accelerates Edge AI Strategy with Broadcom Licensing Agreement, Expanding IoT Connectivity and Wireless Solutions (Insider Monkey)
01:02PM	Strength Seen in Synaptics (SYNA): Can Its 9.1% Jump Turn into More Strength? (Zacks)
Jan-28-25 04:05PM	Synaptics Accelerates Edge AI Strategy with New Broadcom Agreement (GlobeNewswire) +9.11%
Jan-15-25 08:01AM	Synaptics to Report Second Quarter Fiscal 2025 Results on February 6, 2025 (GlobeNewswire) +8.91%
Jan-07-25 11:01AM	Synaptics to Participate at Upcoming Investor Conference Wednesday, January 15, 2025 (GlobeNewswire)
Jan-03-25 03:39PM	Synaptics Gains on Google Collaboration to Advance Edge AI in IoT Applications (GuruFocus.com)
Jan-02-25 12:53PM	Synaptics Stock Surges on Google AI Tech Partnership (Investopedia) +8.07%
12:05PM	Synaptics (SYNA), BlackBerry (BB) Are Among Todays Winners (Insider Monkey)

Synaptics, Inc. engages in the development, marketing, and sale of human interface semiconductor solutions for electronic devices and products. It specializes in custom-designed human interface that enable people to interact with mobile computing, communications, entertainment, and other electronic devices. The company was founded by Federico Faggin and Carver A. Mead in March 1986 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bodensteiner Lisa	See Remarks	Mar 18 '26	Sale	74.83	334	24,993	71,191	Mar 18 06:31 PM
LISA BODENSTEINER	Officer	Mar 18 '26	Proposed Sale	74.56	334	24,903		Mar 18 04:31 PM
Gupta Vikram	See Remarks	Feb 25 '26	Sale	81.57	772	62,972	95,996	Feb 25 09:15 PM
VIKRAM GUPTA	Officer	Feb 25 '26	Proposed Sale	81.06	440	35,666		Feb 25 04:33 PM
Gupta Vikram	See Remarks	Feb 18 '26	Sale	85.00	772	65,620	96,768	Feb 18 08:05 PM
Bodensteiner Lisa	See Remarks	Feb 18 '26	Sale	84.93	576	48,920	72,307	Feb 18 07:12 PM
LISA BODENSTEINER	Officer	Feb 18 '26	Proposed Sale	85.40	576	49,190		Feb 18 04:36 PM
VIKRAM GUPTA	Officer	Feb 18 '26	Proposed Sale	85.40	1,104	94,282		Feb 18 04:36 PM
Patel Rahul G.	See remarks below	Jan 20 '26	Sale	87.21	2,281	198,925	113,601	Jan 21 11:54 AM
Patel Rahul G.	See remarks below	Jan 06 '26	Sale	85.00	2,282	193,970	115,882	Jan 07 02:48 PM
RAHUL PATEL	Director	Jan 06 '26	Proposed Sale	79.16	4,563	361,207		Jan 06 04:26 PM
Patel Rahul G.	See remarks below	Jan 05 '26	Sale	80.00	2,282	182,560	118,164	Jan 06 12:40 PM
RAHUL PATEL	Director	Jan 05 '26	Proposed Sale	75.74	2,282	172,839		Jan 05 04:43 PM
Bodensteiner Lisa	See Remarks	Dec 18 '25	Sale	75.83	336	25,479	74,425	Dec 18 08:28 PM
LISA BODENSTEINER	Officer	Dec 18 '25	Proposed Sale	73.84	336	24,810		Dec 18 04:22 PM
Gupta Vikram	See Remarks	Dec 17 '25	Sale	75.00	694	52,050	100,082	Dec 18 12:54 PM
Gupta Vikram	See Remarks	Dec 12 '25	Sale	80.07	694	55,569	100,776	Dec 15 01:51 PM
VIKRAM GUPTA	Officer	Dec 12 '25	Proposed Sale	80.53	1,388	111,776		Dec 12 04:19 PM
Ganesan Satish	See Remarks	Dec 11 '25	Sale	80.29	18,285	1,468,128	79,351	Dec 12 01:53 PM
SATISH GANESAN	Officer	Dec 11 '25	Proposed Sale	81.29	18,285	1,486,388		Dec 11 04:24 PM
Bodensteiner Lisa	See Remarks	Dec 09 '25	Sale	78.68	7,182	565,050	75,542	Dec 10 04:30 PM
LISA BODENSTEINER	Officer	Dec 09 '25	Proposed Sale	78.00	7,182	560,196		Dec 09 04:23 PM

ALKS

Alkermes plc

SYNA

Synaptics Inc

Upgrade your Finviz experience